{"id":"perimetazine","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"leptryl","offLabel":[],"synonyms":["perimethazine","leptryl","perimetazine"],"timeline":[],"approvals":[],"brandName":"Leptryl","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells have locks on them, and Leptryl has a key that fits into those locks. When it binds to the lock, it helps to regulate the cell's activity, which can help to treat certain conditions. This is a simplified explanation of how Leptryl works at a molecular level.","oneSentence":"Leptryl works by interacting with a specific molecular target to produce its therapeutic effect.","technicalDetail":"Leptryl's mechanism of action involves binding to a specific receptor or enzyme, which triggers a cascade of downstream effects that ultimately lead to its therapeutic outcome."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3431","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=PERIMETAZINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:17:17.697300","biosimilars":[],"competitors":[],"genericName":"perimetazine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"2R880S54IS","CHEBI":"CHEBI:135603","INN_ID":"2391","UMLSCUI":"C0070425","ChEMBL_ID":"CHEMBL2104911","PUBCHEM_CID":"62870","MESH_SUPPLEMENTAL_RECORD_UI":"C003075"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":4,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Leptryl (Perimetazine) is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it is not FDA approved for any indications. The drug's pharmacokinetic properties, such as half-life and bioavailability, are also unknown. Leptryl is owned by an unspecified company, and its generic status is uncertain. Further research is needed to understand its clinical applications and safety profile.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}